Investing

ICON : ICLR

ICLR

Stock Data

$112.85

$5.48 (4.63%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Icon Plc is a global clinical research organization based in Dublin, Ireland, offering a wide range of services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in managing all stages of the clinical development process, from early compound selection through to Phase I-IV clinical studies. Icon Plc provides comprehensive services including clinical trial management, consulting, laboratory services, and post-market commercialization support. With a focus on innovation, Icon Plc supports its clients in bringing new medicines and treatments to market efficiently and effectively.

All ICON Articles

2 Articles

Joel South | Mar 11, 2026 at 10:26 AM EDT

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent…

Omor Ibne Ehsan | Apr 21, 2025 at 9:22 AM EDT

3 Value Stocks Set to Surge, With Up to 190% Upside in 2025

The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift…